Skip to content

Flex4Pharma

Active Risk: not assessed
Private limited companyfounded 2020active for 6 yearsAkkerplein 7, 3090 Overijse, BelgiumKBO/BCE: BE 0755.383.441
Summary

Flex4Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €30,751 and a net result of €18,711. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 66% of 22,382 sector peers (NACE 47, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.

Financials · financial year 2025, micro format

Equity
€30,751▲ 13.7%
2024 · €27,040
Total assets
€59,511▲ 105%
2024 · €29,055
Net result
€18,711▲ 2,504%
2024 · €718
Working capital
€703▼ 97.3%
2024 · €26,064
Trend over the years

2021 to 2025, 5 financial years 2020 to 2025, 6 financial years

The operating result returns to profit in 2025: €26,632 after a loss of €205 in 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€26,632 2025 Net result€18,711 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202020212022202320242025
Operating result-€4,822-€4,219€33,454▲ 693%-€1,249-€205▲ 83.6%€26,632
Net result-€4,874below the sector's middle half-€4,028within the sector's middle half€25,962above the sector's middle half▲ 544%-€1,794within the sector's middle half€718within the sector's middle half€18,711within the sector's middle half▲ 2,504%
Equity-€1,874below the sector's middle half-€2,154below the sector's middle half€28,116within the sector's middle half▲ 1,205%€26,321within the sector's middle half▼ 6.4%€27,040within the sector's middle half▲ 2.7%€30,751within the sector's middle half▲ 13.7%
Total assets€17,300below the sector's middle half-€17,839below the sector's middle half▲ 3.1%€44,486below the sector's middle half▲ 149%€31,292below the sector's middle half▼ 29.7%€29,055below the sector's middle half▼ 7.2%€59,511within the sector's middle half▲ 105%
Debt€19,174-€15,685▼ 18.2%€16,370▲ 4.4%€4,971▼ 69.6%€2,015▼ 59.5%€28,760▲ 1,327%
Working capital-€874within the sector's middle half-€395within the sector's middle half€30,258within the sector's middle half▲ 7,561%€25,515within the sector's middle half▼ 15.7%€26,064within the sector's middle half▲ 2.2%€703within the sector's middle half▼ 97.3%
Solvency-10.8%below the sector's middle half-12.1%within the sector's middle half▲ 22.9pp63.2%above the sector's middle half▲ 51.1pp84.1%above the sector's middle half▲ 20.9pp93.1%above the sector's middle half▲ 9.0pp51.7%within the sector's middle half▼ 41.4pp
Current ratio0.95within the sector's middle half-1.03within the sector's middle half▲ 0.073.35above the sector's middle half▲ 2.326.23above the sector's middle half▲ 2.8913.94above the sector's middle half▲ 7.701.02within the sector's middle half▼ 12.91
Return on assets (ROA)-28.2%below the sector's middle half-22.6%above the sector's middle half▲ 50.8pp58.4%above the sector's middle half▲ 35.8pp-5.7%below the sector's middle half▼ 64.1pp2.5%within the sector's middle half▲ 8.2pp31.4%above the sector's middle half▲ 29.0pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €59,511
Fixed assets €30,048 ▲ 2,979%
Current assets €29,462 ▲ 4.9%
Equity and liabilities €59,511
Equity €30,751 ▲ 13.7%
Debt €28,760 ▲ 1,327%
Debt's share of the balance-sheet total rises from 6.9% to 48.3%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
ROE
60.8%▲
2024 · 2.7%
Debt ≤ 1 year
€28,760▲
2024 · €2,015
Income taxes
€7,624
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€29,055€59,511▲
Fixed assets21/28€976€30,048▲
Tangible fixed assets22/27€476€48▼
Furniture and vehicles24€476€48▼
Financial fixed assets28€500€30,000▲
Current assets29/58€28,079€29,462▲
Amounts receivable within one year40/41€22,508€24,845▲
Trade receivables40€7,905€6,630▼
Other amounts receivable41€14,603€18,215▲
Cash at bank and in hand54/58€4,255€4,273▲
Deferred charges and accrued income490/1€1,316€345▼
Equity and liabilities
Total equity and liabilities10/49€29,055€59,511▲
Equity10/15€27,040€30,751▲
Contributions10/11€3,000€3,000=
Reserves13€24,040€27,751▲
Distributable reserves133€24,040€27,751▲
Profit (loss) carried forward14-€0
Amounts payable17/49€2,015€28,760▲
Amounts payable within one year42/48€2,015€28,760▲
Financial debts43-€1,688
Credit institutions430/8-€1,688
Trade debts44€308€6,677▲
Suppliers440/4€308€6,677▲
Taxes, remuneration and social security45€300€2,624▲
Taxes450/3€300€2,624▲
Other amounts payable47/48€1,407€17,770▲
Income statement Code20242025
Non-recurring operating income76A-€14,500
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€428€428=
Other operating charges640/8€451€465▲
Gross operating margin9900€674€27,525▲
Operating profit (loss)9901-€205€26,632▲
Financial income75/76B€1,037€0▼
Recurring financial income75€1,037€0▼
Financial charges65/66B€113€297▲
Recurring financial charges65€113€297▲
Profit (loss) for the period before taxes9903€718€26,335▲
Income taxes67/77-€7,624
Profit (loss) for the period9904€718€18,711▲
Profit (loss) for the period to be appropriated9905€718€18,711▲
Appropriation of the result
Profit (loss) to be appropriated9906€718€18,711▲
Transfer to equity691/2€718€3,711▲
To other reserves6921€718€3,711▲
Profit to be distributed694/7-€15,000
Return on contributions (dividend)694-€15,000

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202020212022202320242025Change
Non-recurring operating income76A-----€14,500-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€380€428€428€428€428=
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4--€5,046----
Other operating charges640/8-€482€405€448€451€465▲ 3.2%
Gross operating margin9900-€4,335€5,081€39,332-€373€674€27,525▲ 3,986%
Operating profit (loss)9901-€4,822€4,219€33,454-€1,249-€205€26,632-
Financial income75/76B-€0€1,232€772€1,037€0▼ 100%
Recurring financial income75€0€0€1,232€772€1,037€0▼ 100%
Financial charges65/66B-€191€245€1,318€113€297▲ 162%
Recurring financial charges65€53€191€245€1,318€113€297▲ 162%
Profit (loss) for the period before taxes9903-€4,874€4,028€34,441-€1,794€718€26,335▲ 3,566%
Income taxes67/77--€8,479--€7,624-
Profit (loss) for the period9904-€4,874€4,028€25,962-€1,794€718€18,711▲ 2,504%
Profit (loss) for the period to be appropriated9905-€4,874€4,028€25,962-€1,794€718€18,711▲ 2,504%
Line202020212022202320242025Change
Assets
Total assets20/58€17,300€17,839€44,486€31,292€29,055€59,511▲ 105%
Fixed assets21/28-€1,759€1,331€904€976€30,048▲ 2,979%
Tangible fixed assets22/27-€1,759€1,331€904€476€48▼ 89.9%
Furniture and vehicles24-€1,759€1,331€904€476€48▼ 89.9%
Financial fixed assets28----€500€30,000▲ 5,900%
Current assets29/58€17,300€16,080€43,155€30,389€28,079€29,462▲ 4.9%
Stocks and contracts in progress3€6,428€5,500-----
Stocks30/36-€5,500-----
Amounts receivable within one year40/41€7,396€6,327€21,893€22,801€22,508€24,845▲ 10.4%
Trade receivables40-€5,730€1,743€1,255€7,905€6,630▼ 16.1%
Other amounts receivable41-€597€20,150€21,546€14,603€18,215▲ 24.7%
Cash at bank and in hand54/58€1,842€3,582€20,484€6,519€4,255€4,273▲ 0.4%
Deferred charges and accrued income490/1-€671€777€1,068€1,316€345▼ 73.8%
Equity and liabilities
Total equity and liabilities10/49€17,300€17,839€44,486€31,292€29,055€59,511▲ 105%
Equity10/15-€1,874€2,154€28,116€26,321€27,040€30,751▲ 13.7%
Contributions10/11-€3,000€3,000€3,000€3,000€3,000=
Reserves13--€25,116€23,321€24,040€27,751▲ 15.4%
Distributable reserves133--€25,116€23,321€24,040€27,751▲ 15.4%
Profit (loss) carried forward14-€4,874-€846---€0-
Amounts payable17/49€19,174€15,685€16,370€4,971€2,015€28,760▲ 1,327%
Amounts payable within one year42/48€18,174€15,685€12,896€4,874€2,015€28,760▲ 1,327%
Financial debts43-----€1,688-
Credit institutions430/8-----€1,688-
Trade debts44€10,811€4,547-€51€308€6,677▲ 2,066%
Suppliers440/4-€4,547-€51€308€6,677▲ 2,066%
Taxes, remuneration and social security45--€3,600€4,823€300€2,624▲ 775%
Taxes450/3--€3,600€4,823€300€2,624▲ 775%
Other amounts payable47/48-€11,138€9,296-€1,407€17,770▲ 1,163%
Accrued charges and deferred income492/3--€3,474€97---
Line202020212022202320242025Change
Profit (loss) for the period9904-€4,874€4,028€25,962-€1,794€718€18,711▲ 2,504%
+ Depreciation and write-downs630-€380€428€428€428€428=
Operating cash flow (approximation)-€4,874€4,408€26,390-€1,367€1,146€19,139▲ 1,570%
Investment in fixed assets (approximation)--€0€0-€500-€29,500▼ 5,800%
Change in cash-€1,740€16,902-€13,965-€2,264€18-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (6)
Financial year Type Filed Reference
31-12-2025 micro format 06-07-2026 2026-00255679
31-12-2024 micro format 16-07-2025 2025-00273972
31-12-2023 micro format 12-07-2024 2024-00242170
31-12-2022 micro format 29-06-2023 2023-00174732
31-12-2021 micro format 06-07-2022 2022-20150075
31-12-2020 micro format 09-07-2021 2021-33400165

Similar companies · same sector, comparable size

Of the 1,049 active companies whose main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741), figures are known for 640. 379 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.